ArticleCell death & disease2016

Galectin-1 induces hepatocellular carcinoma EMT and sorafenib resistance by activating FAK/PI3K/AKT signaling.

P-F Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.